Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Personalized deep brain stimulation for Tourette syndrome

Official title: MultitArget STereotactic Electrophysiological Recording and Stimulation for Tourette Syndrome

Run by Beijing Tiantan Hospital · NCT06889480 · Data updated 2026-11-12

This study is testing if personalized deep brain stimulation can help people with Tourette syndrome reduce their tics and improve related issues like anxiety and attention problems.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment5 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedMarch 2026
Study endsMarch 2026
Registry record updatedMay 22, 2025
Trial IDNCT06889480 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 60 with a diagnosis of Tourette syndrome who have not responded adequately to standard treatments.

Probably not a fit

Patients with tics attributable to other medical conditions or those who have not had stable treatment for coexisting disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to explore the neural mechanisms of Tourette syndrome (TS) and assess the effectiveness of personalized deep brain stimulation (DBS) in reducing tics and improving associated issues such as anxiety and attention problems. Researchers will utilize advanced techniques like stereoelectroencephalography (SEEG) and electrocorticography (ECoG) to record brain activity in critical areas related to movement and emotion. Participants will undergo DBS treatment under three different conditions over one-month periods to identify the most effective stimulation target for their symptoms.

Why it matters

Potential benefit: If successful, this approach could significantly reduce tics and improve quality of life for patients with Tourette syndrome.

How similar studies have gone: While there have been studies on deep brain stimulation for movement disorders, this specific approach targeting Tourette syndrome is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 and 60 years.
2. Diagnosis of Tourette Syndrome according to DSM-V criteria, defined as:

   i. The presence of multiple motor tics and at least one vocal tic at some point (not necessarily simultaneous).

   ii. Tics that have persisted for more than 1 year from their onset.

   iii. Onset of tics occurring before the age of 18.

   iv. The disorder is not attributable to the physiological effects of a substance or another medical condition.
3. A Yale Global Tic Severity Scale (YGTSS) total score greater than 35 (on a scale of 0-50) for at least 1 year, with a motor tic score of ≥15, and tics being the primary cause of disability.
4. Inadequate response to conservative treatments (standard pharmacological and behavioral therapy).
5. Disease duration of more than 1 year.
6. Any coexisting medical, neurological, or psychiatric disorders have been treated and remain stable for at least 6 months.
7. A stable psychosocial environment.
8. Neuropsychological evaluation demonstrating that the candidate can tolerate the surgical procedure, postoperative follow-up, and potential adverse events.
9. The participant, or his/her legal representative, is able to provide written informed consent.

Exclusion Criteria:

1. Presence of suicidal risk, defined as a score of ≥3 on the suicide-related items of the Hamilton Depression Rating Scale (HAMD).
2. History of drug or alcohol dependence within the past 6 months.
3. Abnormal brain structure as indicated by CT or MRI scans.
4. Presence of any condition that could lead to surgical failure or interfere with postoperative management.
5. Diagnosis of factitious disorder, malingering, or psychogenic tics.
6. Contraindications to neurosurgical procedures (e.g., history of cerebral infarction, hydrocephalus, cerebral atrophy, or post-stroke sequelae).
7. Contraindications for CT/MRI scanning (e.g., claustrophobia).
8. Pregnancy or lactation, or a positive pregnancy test prior to randomization.
9. Contraindications to general anesthesia (e.g., severe arrhythmia, severe anemia, hepatic or renal dysfunction).
10. Expected survival of less than 12 months.
11. Participation in other interventional clinical studies that may influence outcome assessments.
12. Any other condition that, in the investigator's judgment, renders the candidate unsuitable for participation or poses a significant risk (e.g., inability to understand study procedures or poor adherence).

Where it's running

  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Jianguo Zhang, M.D., Ph.D. — Beijing Tiantan Hospital
  • Study coordinator: Hutao Xie, M.D., Ph.D.
  • Email: xieht0123@163.com
  • Phone: +8618756921517

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.